Page last updated: 2024-12-10
1,5-anhydroglucitol-6-phosphate
## 1,5-Anhydroglucitol-6-phosphate (1,5-AG-6-P)
**What is it?**
1,5-Anhydroglucitol-6-phosphate (1,5-AG-6-P) is a **phosphorylated form of 1,5-anhydroglucitol (1,5-AG)**, a naturally occurring sugar alcohol found in humans and animals. It is synthesized from glucose in the liver and is primarily found in the blood and urine.
**How is it formed?**
1,5-AG is produced by the enzyme aldose reductase from glucose. Once formed, 1,5-AG is further phosphorylated by hexokinase to produce 1,5-AG-6-P.
**Why is it important for research?**
1,5-AG-6-P is an important research tool because it plays a critical role in **glucose homeostasis** and is a **potential biomarker for type 2 diabetes**.
**Key aspects of its research importance:**
* **Reflects long-term blood glucose levels:** 1,5-AG-6-P is taken up by cells and its levels in the blood reflect the average blood glucose levels over the preceding 1-2 weeks. This makes it a valuable tool for understanding long-term glucose control in patients.
* **Potential biomarker for type 2 diabetes:** 1,5-AG-6-P levels are often lower in individuals with type 2 diabetes. Researchers are investigating its potential as a reliable biomarker for early detection and monitoring of the disease.
* **Mechanism of action in glucose control:** 1,5-AG-6-P is thought to act as a competitive inhibitor of hexokinase, the enzyme that phosphorylates glucose. This inhibition could contribute to the regulation of glucose uptake and metabolism.
* **Insights into glucose metabolism:** Studying 1,5-AG-6-P pathways provides valuable information on the complex mechanisms involved in glucose homeostasis, including its interaction with other metabolic processes.
* **Therapeutic potential:** Further research on 1,5-AG-6-P's role in glucose control could lead to the development of new treatments for diabetes and other metabolic disorders.
**Current research:**
Ongoing research is focusing on:
* Elucidating the precise mechanisms by which 1,5-AG-6-P regulates glucose metabolism.
* Validating its effectiveness as a biomarker for type 2 diabetes diagnosis and monitoring.
* Exploring the potential of 1,5-AG-6-P as a therapeutic target for managing diabetes.
In conclusion, 1,5-AG-6-P is a fascinating molecule with significant implications for our understanding of glucose homeostasis and the development of new diagnostic and therapeutic tools for diabetes.
Cross-References
ID Source | ID |
PubMed CID | 3081444 |
SCHEMBL ID | 247669 |
MeSH ID | M0040097 |
Synonyms (8)
Synonym |
17659-59-5 |
d-glucitol, 1,5-anhydro-, 6-(dihydrogen phosphate) |
1,5-anhydroglucitol-6-phosphate |
[(2r,3s,4r,5s)-3,4,5-trihydroxyoxan-2-yl]methyl dihydrogen phosphate |
1,5-anhydro-6-o-phosphono-d-glucitol |
SCHEMBL247669 |
DTXSID20170158 |
Q27451489 |
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.37
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.37 (24.57) | Research Supply Index | 2.08 (2.92) | Research Growth Index | 4.45 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (14.29%) | 6.00% |
Case Studies | 1 (14.29%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (71.43%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |